Controlled Release Aural Pressure Modulator for Inner Ear Homeostasis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for otic disorders, such as Meniere's disease, face challenges due to the susceptibility of the inner ear to infections, requiring stringent sterility and compatibility with the inner ear environment, and existing formulations often cause discomfort and systemic toxicities, with limited effectiveness in maintaining aural pressure homeostasis.
Innovation Solution
Development of controlled release formulations and compositions that are sterilized to low bioburden, compatible with the inner ear environment, and administered at reduced frequency, using aural pressure modulating agents like vasopressin receptor modulators, prostaglandins, or estrogen-related receptor modulators, which are delivered directly to the ear to maintain aural pressure homeostasis and reduce systemic side effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are administered to treat otic disorders, then therapeutic effect is achieved, but systemic toxicities and discomfort occur
Solution Approach 1:
The patent uses controlled-release formulations as an intermediary delivery system that transports aural pressure modulating agents directly to the inner ear through the round window membrane, avoiding systemic circulation and thereby eliminating systemic toxicities and discomfort while maintaining therapeutic effectiveness
Solution Approach 2:
The invention implements local administration of aural pressure modulating agents directly to the inner ear environment, creating localized therapeutic action at the site of pathology (Meniere's disease) without affecting other body systems, thus resolving the contradiction between therapeutic effect and systemic side effects
2Reliability
If existing formulations are used to maintain aural pressure homeostasis, then some therapeutic benefit is achieved, but inner ear sterility is compromised
Solution Approach 1:
The patent changes the formulation parameters by using controlled-release delivery systems with specific excipients and formulations that are designed to maintain sterility while delivering therapeutic agents, achieving both aural pressure homeostasis and sterility maintenance through optimized formulation parameters
3Reliability
If frequent administration is used to maintain therapeutic levels, then effective treatment is achieved, but patient comfort and compliance deteriorate
Solution Approach 1:
The controlled-release formulations provide continuous delivery of aural pressure modulating agents over extended periods, maintaining constant therapeutic levels in the inner ear without requiring frequent re-administration, thereby improving patient comfort and compliance while ensuring reliable therapeutic effect
Solution Approach 2:
The invention uses dynamic controlled-release mechanisms that adjust the release rate of therapeutic agents based on local conditions in the inner ear, providing sustained therapeutic levels adaptively without requiring frequent patient intervention, thus resolving the contradiction between effective treatment and patient comfort
Data Source
AI summary
Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with aural pressure modulating agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).